Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury.

No Thumbnail Available
Authors
Chen, Y-T
Yang, C-C
Zhen, Y-Y
Wallace, Christopher G
Yang, J-L
Sun, C-K
Tsai, T-H
Sheu, J-J
Chua, S
Chang, C-L
Journal
Stem Cell Research & Therapy
Type
Journal Article
Research Support, Non-U.S. Gov't
Publisher
BioMed Central
Rights
Archived with thanks to Stem cell research & therapy
This study tested the hypothesis that cyclosporine (CsA)-supported syngeneic adipose-derived mesenchymal stem cell (ADMSC) therapy offered superior attenuation of acute ischemia-reperfusion (IR) kidney injury to either therapy alone.
Citation
Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury. 2013, 4 (3):62 Stem Cell Res Ther
Note
This article is freely available online via Open Access. Click on the Additional Link above to access the full-text via the publisher's site.